As of 3:59pm ET
| +0.02 / +1.18%|
The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 42.00, with a high estimate of 42.00 and a low estimate of 42.00. The median estimate represents a +2,341.86% increase from the last price of 1.72.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.